Dejmek A - Search Results

1

Immune effector monocyte-neutrophil cooperation induced by the primary tumor prevents metastatic progression of breast cancer.

Hagerling C, Gonzalez H, Salari K, Wang CY, Lin C, Robles I, van Gogh M, Dejmek A, Jirström K, Werb Z. Hagerling C, et al. Among authors: dejmek a. Proc Natl Acad Sci U S A. 2019 Oct 22;116(43):21704-21714. doi: 10.1073/pnas.1907660116. Epub 2019 Oct 7. Proc Natl Acad Sci U S A. 2019. PMID: 31591235 Free PMC article.

2

Wnt-5a protein expression in primary dukes B colon cancers identifies a subgroup of patients with good prognosis.

Dejmek J, Dejmek A, Säfholm A, Sjölander A, Andersson T. Dejmek J, et al. Among authors: dejmek a. Cancer Res. 2005 Oct 15;65(20):9142-6. doi: 10.1158/0008-5472.CAN-05-1710. Cancer Res. 2005. PMID: 16230369

3

Optimization of a battery using nine immunocytochemical variables for distinguishing between epithelial mesothelioma and adenocarcinoma.

Dejmek A, Brockstedt U, Hjerpe A. Dejmek A, et al. APMIS. 1997 Nov;105(11):889-94. doi: 10.1111/j.1699-0463.1997.tb05099.x. APMIS. 1997. PMID: 9393561

4

Weak telomerase activity in malignant cells in metastatic serous effusions: correlation to short survival time.

Zendehrokh N, Franzen L, Dejmek A. Zendehrokh N, et al. Among authors: dejmek a. Acta Cytol. 2007 May-Jun;51(3):412-6. doi: 10.1159/000325756. Acta Cytol. 2007. PMID: 17536544

5

Lower proliferation rate in metastatic effusion mesothelial cells than in benign effusions.

Rehnberg J, Zendehrokh N, Dejmek A. Rehnberg J, et al. Among authors: dejmek a. Anal Quant Cytol Histol. 2007 Aug;29(4):217-20. Anal Quant Cytol Histol. 2007. PMID: 17879629

6

The reactivity to CK5/6 antibody in tumor cells from non-small cell lung cancers shed into pleural effusions predicts survival.

Dejmek JS, Dejmek A. Dejmek JS, et al. Among authors: dejmek a. Oncol Rep. 2006 Mar;15(3):583-7. Oncol Rep. 2006. PMID: 16465416

7

PD-L1 Expression in Non-Small Cell Lung Cancer Specimens: Association with Clinicopathological Factors and Molecular Alterations.

Mansour MSI, Malmros K, Mager U, Ericson Lindquist K, Hejny K, Holmgren B, Seidal T, Dejmek A, Dobra K, Planck M, Brunnström H. Mansour MSI, et al. Among authors: dejmek a. Int J Mol Sci. 2022 Apr 19;23(9):4517. doi: 10.3390/ijms23094517. Int J Mol Sci. 2022. PMID: 35562908 Free PMC article.

8

Immunohistochemical reactivity in mesothelioma and adenocarcinoma: a stepwise logistic regression analysis.

Dejmek A, Hjerpe A. Dejmek A, et al. APMIS. 1994 Apr;102(4):255-64. doi: 10.1111/j.1699-0463.1994.tb04873.x. APMIS. 1994. PMID: 8011302

9

Carcinoembryonic antigen-like reactivity in malignant mesothelioma. A comparison between different commercially available antibodies.

Dejmek A, Hjerpe A. Dejmek A, et al. Cancer. 1994 Jan 15;73(2):464-9. doi: 10.1002/1097-0142(19940115)73:2<464::aid-cncr2820730235>3.0.co;2-#. Cancer. 1994. PMID: 8293414 Clinical Trial.

10

Immunoreactivity of pleural malignant mesotheliomas to glutathione S-transferases.

Dejmek A, Brockstedt U, Hjerpe A. Dejmek A, et al. APMIS. 1998 Apr;106(4):489-94. doi: 10.1111/j.1699-0463.1998.tb01376.x. APMIS. 1998. PMID: 9637272

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48 results

Search Page

Filters